S.Amdt. 144

SA 144. Ms. KLOBUCHAR (for herself and Ms. Warren) submitted an
amendment intended to be proposed by her to the concurrent resolution
S. Con. Res. 3, setting forth the congressional budget for the United
States Government for fiscal year 2017 and setting forth the
appropriate budgetary levels for fiscal years 2018 through 2026; which
was ordered to lie on the table; as follows:

At the end of title IV, add the following:

SEC. 4__. POINT OF ORDER AGAINST LEGISLATION THAT WOULD
RESTRICT TRANSPARENCY IN THE RELATIONSHIP
BETWEEN PHYSICIANS AND MANUFACTURERS OF DRUGS,
DEVICES, BIOLOGICAL PRODUCTS, OR MEDICAL
SUPPLIES, INCLUDING THROUGH REPEAL OF THE
PHYSICIAN PAYMENTS SUNSHINE ACT PROVIDED UNDER
THE PATIENT PROTECTION AND AFFORDABLE CARE ACT.

(a) Point of Order.--It shall not be in order in the Senate
to consider any bill, joint resolution, motion, amendment,
amendment between the Houses, or conference report that would
restrict transparency in the relationship between physicians
and manufacturers of drugs, devices, biological products, or
medical supplies, including through repeal of the Physician
Payments Sunshine Act provided under section 6002 of the
Patient Protection and Affordable Care Act.
(b) Waiver and Appeal.--Subsection (a) may be waived or
suspended in the Senate only by an affirmative vote of three-
fifths of the Members, duly chosen and sworn. An affirmative
vote of three-fifths of the Members of the Senate, duly
chosen and sworn, shall be required to sustain an appeal of
the ruling of the Chair on a point of order raised under
subsection (a).
______